**EPIC EHR - Inpatient Progress Note**  
**Patient:** Benito Conroy  
**MRN:** 002948234  
**DOB:** 05/25/1977  
**Sex:** Male  
**Admit Date:** 4/26/2024  
**Attending:** Dr. L. Thompson  
**Location:** MICU, Room 12B  
**Note Date:** 5/2/2024  
**Encounter Type:** ICU - Daily Progress Note

---

### CHIEF COMPLAINT  
Shortness of breath, chest pain, and orthopnea.

---

### HOSPITAL COURSE SUMMARY

Mr. Benito Conroy, a 46-year-old male with past medical history significant for obesity (BMI 30.2), chronic sinusitis, chronic pain, osteoarthritis, and recent acute bronchitis, presented to the ED with progressive dyspnea, chest discomfort, and lower extremity edema. He had a syncopal episode at home. Initial workup revealed evidence of acute decompensated heart failure with reduced ejection fraction (EF 15% on TTE), and he rapidly developed cardiogenic shock requiring transfer to the MICU. Despite aggressive diuresis and inotropic support, Benito developed worsening end-organ perfusion and hypotension, necessitating placement of a temporary percutaneous left ventricular assist device (Impella CP) for hemodynamic support on hospital day 2.

His hospital course was complicated by transient acute kidney injury, mild transaminitis, and delirium. He is currently weaning from inotropes and the heart pump, with improving end-organ function.

---

### PAST MEDICAL HISTORY  
- Obesity (BMI 30.2)  
- Chronic sinusitis  
- Viral sinusitis (recent)  
- Osteoarthritis of knee  
- Chronic pain (on opioids)  
- Acute bronchitis (recent)

### SURGICAL HISTORY  
- Right knee arthroscopy (2015)

### HOME MEDICATIONS  
- Naproxen sodium 220 mg PO PRN  
- Acetaminophen 325 mg PO PRN  
- Oxycodone ER 15 mg PO BID

### ALLERGIES  
- NKDA

---

### VITALS (selected, see flowsheet for full details)

| Date        | Temp (Â°C) | HR (bpm) | BP (mmHg) | RR | SpO2 | Wt (kg) | Pain |
|-------------|-----------|----------|-----------|----|------|---------|------|
| 4/26/2024   | 36.8      | 112      | 92/54     | 22 | 95%  | 100.2   | 7    |
| 4/27/2024   | 37.2      | 108      | 85/48     | 24 | 94%  | 99.5    | 5    |
| 4/28/2024   | 37.4      | 104      | 88/52     | 19 | 97%  | 99.1    | 4    |
| 4/29/2024   | 36.7      | 98       | 108/65    | 16 | 98%  | 98.7    | 2    |
| 5/1/2024    | 36.5      | 84       | 116/74    | 14 | 99%  | 98.2    | 2    |

---

### LABS

#### CBC/Chemistry Trends

| Date      | WBC (K/uL) | Hgb (g/dL) | Hct (%) | Plt (K/uL) | Na (mmol/L) | K (mmol/L) | Cl (mmol/L) | CO2 (mmol/L) | BUN (mg/dL) | Cr (mg/dL) | Glu (mg/dL) |
|-----------|------------|------------|---------|------------|-------------|------------|-------------|--------------|-------------|------------|-------------|
| 4/26/24   | 7.3        | 12.5       | 44.2    | 334        | 137         | 4.8        | 108         | 24           | 34          | 2.12       | 109         |
| 4/27/24   | 8.7        | 11.8       | 41.5    | 312        | 135         | 5.2        | 106         | 20           | 39          | 2.38       | 140         |
| 4/28/24   | 9.0        | 10.9       | 39.2    | 299        | 135         | 4.7        | 106         | 21           | 42          | 2.41       | 132         |
| 4/29/24   | 8.0        | 11.3       | 40.4    | 276        | 137         | 4.4        | 108         | 23           | 32          | 1.89       | 118         |
| 4/30/24   | 7.6        | 11.5       | 41.0    | 288        | 138         | 4.2        | 109         | 24           | 25          | 1.52       | 107         |
| 5/1/24    | 7.5        | 12.0       | 42.7    | 295        | 139         | 4.3        | 110         | 24           | 21          | 1.38       | 102         |
| 5/2/24    |  --        | 11.8       |   --    |  --        | 137         | 4.4        | 108         | 23           | 18          | 1.21       |  --         |

#### Additional Labs

| Date      | Troponin I (ng/mL) | AST (U/L) | ALT (U/L) | Alk Phos (U/L) | Total Bili (mg/dL) | BNP (pg/mL)  | INR | PT (sec) |
|-----------|--------------------|-----------|-----------|----------------|--------------------|--------------|-----|----------|
| 4/26/24   | 0.12               | 43        | 61        | 128            | 1.2                | 2870         | 1.1 | 13.4     |
| 4/27/24   | 0.21               | 56        | 77        | 162            | 1.5                | 3230         | 1.2 | 14.2     |
| 4/28/24   | 0.17               | 49        | 62        | 139            | 1.0                | 2100         | --  | --       |
| 4/30/24   | 0.07               | 36        | 55        | 119            | 0.9                | 1290         | 1.1 | 13.8     |

---

### IMAGING

- **TTE (4/26/24):** Severe global hypokinesis, LVEF 15%, mild MR, dilated LV, moderate RV dysfunction.
- **CXR (4/27/24):** Pulmonary vascular congestion, small bilateral pleural effusions.
- **Renal US (4/28/24):** No hydronephrosis, normal size, increased echogenicity.

---

### ASSESSMENT & PLAN (Problem-Oriented)

**1. Cardiogenic Shock (Acute on Chronic Systolic HF):**  
- Presented with shock refractory to diuretics and inotropes, required Impella CP placement on HD#2.  
- Now improving, weaning from inotropes, Impella flows stable, MAP > 65.  
- *Plan:* Continue Impella support, daily TTE for LV recovery, monitor end-organ perfusion (lactate, urine output), plan for device wean in 48h if stable.

**2. Acute Kidney Injury (pre-renal, multifactorial):**  
- Likely related to low cardiac output, improved post-Impella.  
- *Plan:* Renal function improving, continue to monitor, avoid nephrotoxins, adjust diuretics as tolerated.

**3. Decompensated Heart Failure (HFrEF):**  
- Now euvolemic, on IV furosemide; transitioned to oral as tolerated.  
- *Plan:* Continue aggressive heart failure regimen, uptitrate GDMT as able, salt/fluid restriction.

**4. Transaminitis:**  
- Mild, likely ischemic hepatitis from shock state, now resolving.  
- *Plan:* Monitor LFTs, no hepatotoxic meds.

**5. Delirium:**  
- ICU-related, fluctuating course, now improving.  
- *Plan:* Non-pharmacologic interventions, minimize sedation.

**6. Chronic Pain/Osteoarthritis:**  
- Home opioids, now on reduced dosing, acetaminophen PRN.  
- *Plan:* Pain consult, consider PT/OT, avoid NSAIDs due to AKI.

**7. Obesity:**  
- BMI 30.2, risk factor for HF and complications.  
- *Plan:* Nutrition consult, discuss long-term weight management.

**8. Chronic Sinusitis, Viral Sinusitis, Recent Acute Bronchitis:**  
- No current infectious symptoms, improved.  
- *Plan:* Supportive care, monitor for secondary infection.

---

### MEDICATIONS (ACTIVE)

- Furosemide IV 40 mg q8h (weaning)
- Milrinone drip (weaning)
- Oxycodone ER 10 mg PO BID
- Acetaminophen 650 mg PO q6h PRN
- Heparin drip (per Impella protocol)
- Metoprolol succinate 12.5 mg PO daily (initiated 4/30)
- Lisinopril 2.5 mg PO daily (initiated 5/1)
- Atorvastatin 40 mg PO daily

---

### CONSULTANTS  
- Cardiology, Heart Failure Service  
- Nephrology  
- Pain Management  
- Nutrition

---

### DISPOSITION  
- Remains in MICU. Anticipate transfer to step-down once Impella removed and hemodynamics stable.

---

### SIGNED  
Dr. Lydia Thompson, MD  
MICU/Heart Failure  
5/2/2024 10:19AM

---

**[End of Note]**
